Skip to content

Advanced Biomed Inc

ADVB

CIK 0001941029

← back to feed
Revenue (TTM)
—
Q3 Mar 2026
Net Income (TTM)
$4.6M
−17.1% YoY Q3 Mar 2026
EPS Diluted (TTM)
−$1.44
−14.3% YoY Q3 Mar 2026
Gross Margin
—
Q3 Mar 2026
Operating Margin
—
Q3 Mar 2026
Net Margin
—
Q3 Mar 2026
Free Cash Flow (TTM)
−$5.86M
Q3 Mar 2026
Cash
$2.6M
Q3 Mar 2026
Total Debt
—
Q3 Mar 2026
Shares Outstanding
1.38M sh
Q3 Mar 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings